However, although the use of ICIs has brought benefits to patients with gastric cancer, some cases were not sensitive to ICIs, even if they were patients with PD-1/PD-L1 positive and microsatellite instability-high (MSI-H) (11, 12). Here, CD274 is linked to gastric cancer.